1,950
Participants
Start Date
September 30, 2015
Primary Completion Date
January 25, 2023
Study Completion Date
January 25, 2023
Indomethacin 100 mg rectally immediately after ERCP, NO prophylactic pancreatic stent placement
Indomethacin 100 mg rectally immediately after ERCP AND prophylactic pancreatic stent placement
Univesrity of Southern California, Los Angeles
University of Colorado, Denver
The Florida Hospital, Orlando
Emory University, Atlanta
Northwestern University, Chicago
University of Kansas, Kansas City
Johns Hopkins University, Baltimore
University of Michigan, Ann Arbor
Washington University, St Louis
Dartmouth University, Lebanon
Case Western Reserve University, Cleveland
The Ohio State University Wexner Medical Center, Columbus
Oregon Health & Science University, Portland
University of Pittsburgh, Pittsburgh
Medical University of South Carolina, Charleston
Vanderbilt University, Nashville
Virginia Mason Medical Center, Seattle
Medical College of Wisconsin, Milwaukee
University of Calgary, Calgary
McGill University, Montreal
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Medical University of South Carolina
OTHER